Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2020-01-22 Earnings Release
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Full Year Trading Update
Earnings Release Classification · 98% confidence The document is identified by the RNS Number (5077A) and explicitly states it is an 'unaudited trading update for the year ended 31 December 2019' released ahead of the audited results announcement. This content, providing key financial highlights (revenue, profit expectations, debt reduction) for a period, aligns perfectly with an Earnings Release (ER). Although it is distributed via RNS, the specific content nature (trading update/financial highlights) makes ER the most precise classification. It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but rather the preliminary announcement of results. FY 2019
2020-01-22 English
Block Listing Six Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and the explicit mention that the information is provided by RNS, the news service of the London Stock Exchange. The content details a 'Block Listing Six Monthly Return' concerning the status of securities under various share option plans over a specific period (June 28, 2019, to December 28, 2019). This type of routine regulatory update regarding the issuance or allotment of shares under employee schemes is a specific type of regulatory announcement. While it relates to capital/shares, it is primarily a mandatory disclosure filing via the RNS system. Since it is a formal, structured regulatory announcement that doesn't fit perfectly into the more specific categories like DIRS, DIV, or SHA (which usually announce the *change* itself rather than the periodic reconciliation/return), the most appropriate general classification for a standard, non-financial results regulatory disclosure is RNS (Regulatory Filings). Given the short length and the nature of the filing (a return/update), RNS is the best fit over a more substantive report type.
2020-01-06 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory news service announcement from the London Stock Exchange. The content explicitly states it is a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, detailing the 'Total Voting Rights' as of a specific date (31 December 2019). This type of mandatory disclosure regarding the total number of shares and voting rights is a standard regulatory filing that doesn't fit into the more specific categories like Earnings Release (ER), Annual Report (10-K), or Director's Dealing (DIRS). Since it is a formal regulatory announcement that doesn't fit a more precise category, the most appropriate classification is the general Regulatory Filings category (RNS).
2020-01-03 English
NOTIFICATION OF MAJOR HOLDINGS
Major Shareholding Notification Classification · 99% confidence The document explicitly contains the header "RNS Number : 6092Y" and the footer mentions "This information is provided by RNS, the news service of the London Stock Exchange." The content is a "TR-1: Standard form for notification of major holdings," which details changes in share ownership thresholds (crossing from 6.12% to 9.19%). This type of mandatory regulatory disclosure regarding significant shareholdings is a specific type of regulatory filing. While it relates to share ownership, the primary classification for mandatory regulatory announcements distributed via services like RNS, especially when they don't fit perfectly into other specific categories like Director's Dealing (DIRS) or Share Issue (SHA), is often best captured by the general regulatory filing code or the specific major shareholding notification code if available. Reviewing the definitions, 'Major Shareholding Notification' (MRQ) is the most precise fit for a TR-1 form detailing changes in major holdings. However, since the document is clearly distributed via RNS and is a standard regulatory notification, RNS (Regulatory Filings) is also a strong candidate if MRQ is not intended for TR-1 forms specifically. Given the explicit presence of 'TR-1: Standard form for notification of major holdings' and the resulting change in percentage ownership, MRQ (Major Shareholding Notification) is the most accurate classification based on content, even though it is distributed via RNS.
2020-01-02 English
Grant of Options to Directors
Director's Dealing Classification · 98% confidence The document is an RNS announcement dated December 6, 2019, detailing the 'Grant of Options to Directors' (PDMRs) of Alliance Pharma PLC. It explicitly mentions the notification is made in accordance with the EU Market Abuse Regulation and includes detailed tables showing the grant of share options to the CEO and CFO. This type of filing, reporting personal share transactions or option grants to directors/insiders, falls under the category of Director's Dealing (DIRS). Although it involves remuneration elements, the core action is the transaction/grant of securities by insiders, making DIRS the most specific fit over DEF 14A (which is typically for full remuneration reports).
2019-12-06 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document explicitly starts with 'RNS Number : 8923V' and concludes with a statement that 'This information is provided by RNS, the news service of the London Stock Exchange.' The content is a 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights held by a shareholder (MVM Partners LLP) in Alliance Pharma PLC, crossing a notification threshold. This type of mandatory disclosure regarding significant share ownership changes falls directly under the definition of 'Major Shareholding Notification' (MRQ). Although it is distributed via RNS, the core subject matter is the change in major holding, making MRQ the most specific and accurate classification.
2019-12-05 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.